featured
Long-Term Safety and Efficacy of Alemtuzumab for Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Alemtuzumab Treatment of Multiple Sclerosis: Long-Term Safety and Efficacy
J. Neurol. Neurosurg. Psychiatr. 2015 Feb 01;86(2)208-215, O Tuohy, L Costelloe, G Hill-Cawthorne, I Bjornson, K Harding, N Robertson, K May, T Button, L Azzopardi, O Kousin-Ezewu, MT Fahey, J Jones, DA Compston, A ColesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.